Eligibility for Car T-Cell Therapy: An Analysis of Selection Criteria and Survival Outcomes in Chemorefractory DLBCL

American Journal of Hematology - United States
doi 10.1002/ajh.25411
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Target Selection for CAR-T Therapy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Teaming Up for CAR-T Cell Therapy

Haematologica
Hematology
2019English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Accelerating CAR Therapy in CLL: The Development and Challenges of CAR T Cell Therapy for Chronic Lymphocytic Leukemia

American Journal of Hematology
Hematology
2019English

Eligibility Criteria in Paravertebral Block Meta-Analysis

Anaesthesia
AnesthesiologyPain Medicine
2017English

Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy

American Journal of Hematology
Hematology
2019English

First-Ever CAR T-Cell Therapy Approved in U.S.

Cancer Discovery
Oncology
2017English

The Future: In Vivo CAR T Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy